No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CSL240816P430000
- 11.31
- 0.000.00%
15min DelayTrading Jul 16 12:50 ET
0.00High0.00Low
0.00Open11.31Pre Close0 Volume3 Open Interest430.00Strike Price0.00Turnover37.34%IV2.04%PremiumAug 16, 2024Expiry Date2.57Intrinsic Value100Multiplier24DDays to Expiry8.74Extrinsic Value100Contract SizeAmericanOptions Type-0.4936Delta0.0097Gamma24.56Leverage Ratio-0.3112Theta-0.1308Rho-12.12Eff Leverage0.4414Vega
Intraday
- 5D
- Daily
News
Are Robust Financials Driving The Recent Rally In Carlisle Companies Incorporated's (NYSE:CSL) Stock?
Here's Why Madison Mid Cap Fund Trimmed Carlisle Companies Incorporated (CSL)
(CSL) - Analyzing Carlisle Companies's Short Interest
Express News | Carlisle Companies Inc - Stephen Aldrich Elevated to CFO for Ccm
Express News | Carlisle Companies Announces Finance Leadership Changes
Express News | Carlisle Companies Inc : Jefferies Raises Target Price to $430 From $400
Comments
The share price has tracked EPS growth, suggesting market sentiment towards the shares remains steady. The stock's recent performance has improved, with a better one-year total shareholder return than the five-year return. Dividends have enhanced the total shareholder return.
CSL anticipates robust annualized double-digit earnings growth over the medium term, driven by strong patient demand for its immunoglobulins franchise. The company has bounced back from the pandemic's impact on its blood plasma collections.
The positive trends in Carlisle Companies' ROCE and its ability to consistently reinvest in itself make it an attractive investment. Investors are expecting more growth in the future. However, it's important to check if these trends will continue.
The stock is seen as overpriced by valuation models, making it less attractive for purchase. With the company's low likelihood of significant earnings growth, its investment appeal is diminished. Profits could be made if share prices meet realistic values.
Read more